RAINBOW Stock Overview
Operates a multi-specialty paediatric and obstetrics, and gynaecology hospital chain in India.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 3/6 |
Past Performance | 2/6 |
Financial Health | 4/6 |
Dividends | 1/6 |
Rewards
Risk Analysis
No risks detected for RAINBOW from our risk checks.
Rainbow Children's Medicare Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹1,196.95 |
52 Week High | ₹1,649.00 |
52 Week Low | ₹992.95 |
Beta | 0.30 |
11 Month Change | 0.97% |
3 Month Change | -14.13% |
1 Year Change | 12.24% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 165.87% |
Recent News & Updates
Recent updates
Earnings Miss: Rainbow Children's Medicare Limited Missed EPS By 5.1% And Analysts Are Revising Their Forecasts
Aug 16Rainbow Children's Medicare (NSE:RAINBOW) Is Experiencing Growth In Returns On Capital
Jun 26Rainbow Children's Medicare (NSE:RAINBOW) Strong Profits May Be Masking Some Underlying Issues
May 27Analysts Have Made A Financial Statement On Rainbow Children's Medicare Limited's (NSE:RAINBOW) Full-Year Report
May 23Is Now The Time To Put Rainbow Children's Medicare (NSE:RAINBOW) On Your Watchlist?
May 07Some Shareholders Feeling Restless Over Rainbow Children's Medicare Limited's (NSE:RAINBOW) P/E Ratio
Mar 20Returns At Rainbow Children's Medicare (NSE:RAINBOW) Are On The Way Up
Feb 13Is Now The Time To Put Rainbow Children's Medicare (NSE:RAINBOW) On Your Watchlist?
Jan 18Impressive Earnings May Not Tell The Whole Story For Rainbow Children's Medicare (NSE:RAINBOW)
Nov 07Here's Why Rainbow Children's Medicare (NSE:RAINBOW) Has Caught The Eye Of Investors
Oct 18A Look At The Fair Value Of Rainbow Children's Medicare Limited (NSE:RAINBOW)
Aug 29With EPS Growth And More, Rainbow Children's Medicare (NSE:RAINBOW) Makes An Interesting Case
Jul 08Earnings Beat: Rainbow Children's Medicare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
May 18Getting In Cheap On Rainbow Children's Medicare Limited (NSE:RAINBOW) Is Unlikely
Feb 11Are Investors Undervaluing Rainbow Children's Medicare Limited (NSE:RAINBOW) By 24%?
Sep 20Shareholder Returns
RAINBOW | IN Healthcare | IN Market | |
---|---|---|---|
7D | -2.5% | -0.4% | -0.5% |
1Y | 12.2% | 42.1% | 41.2% |
Return vs Industry: RAINBOW underperformed the Indian Healthcare industry which returned 42.1% over the past year.
Return vs Market: RAINBOW underperformed the Indian Market which returned 41.2% over the past year.
Price Volatility
RAINBOW volatility | |
---|---|
RAINBOW Average Weekly Movement | 4.4% |
Healthcare Industry Average Movement | 5.7% |
Market Average Movement | 6.7% |
10% most volatile stocks in IN Market | 9.6% |
10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: RAINBOW has not had significant price volatility in the past 3 months.
Volatility Over Time: RAINBOW's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1998 | 3,940 | Ramesh Kancharla | www.rainbowhospitals.in |
Rainbow Children's Medicare Limited operates a multi-specialty paediatric and obstetrics, and gynaecology hospital chain in India. The company provides various medical and healthcare services for children and women. Rainbow Children’s Medicare Limited was incorporated in 1998 and is based in Hyderabad, India.
Rainbow Children's Medicare Limited Fundamentals Summary
RAINBOW fundamental statistics | |
---|---|
Market cap | ₹121.55b |
Earnings (TTM) | ₹2.16b |
Revenue (TTM) | ₹13.40b |
56.4x
P/E Ratio9.1x
P/S RatioIs RAINBOW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RAINBOW income statement (TTM) | |
---|---|
Revenue | ₹13.40b |
Cost of Revenue | ₹3.76b |
Gross Profit | ₹9.64b |
Other Expenses | ₹7.49b |
Earnings | ₹2.16b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 21.23 |
Gross Margin | 71.96% |
Net Profit Margin | 16.09% |
Debt/Equity Ratio | 60.5% |
How did RAINBOW perform over the long term?
See historical performance and comparison